Eye movement alterations in presymptomatic C9orf72 expansion gene carriers.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 21 01 2021
accepted: 05 03 2021
revised: 04 03 2021
pubmed: 13 3 2021
medline: 14 8 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

The clinical manifestation of amyotrophic lateral sclerosis (ALS) is characterized by motor neuron degeneration, whereas frontotemporal dementia (FTD) patients show alterations of behavior and cognition. Both share repeat expansions in C9orf72 as the most prevalent genetic cause. Before disease-defining symptoms onset, structural and functional changes at cortical level may emerge in C9orf72 carriers. Here, we characterized oculomotor parameters and their association to neuropsychological domains in apparently asymptomatic individuals with mutations in ALS/FTD genes. Forty-eight carriers of ALS genes, without any clinical symptoms underwent video-oculographic examination, including 22 subjects with C9orf72 mutation, 17 with SOD1, and 9 with other ALS associated gene mutations (n = 3 KIF5A; n = 3 FUS/FUS + TBK1; n = 1 NEK1; n = 1 SETX; n = 1 TDP43). A total of 17 subjects underwent a follow-up measurement. Data were compared to 54 age- and gender-matched healthy controls. Additionally, mutation carriers performed a neuropsychological assessment. In comparison to controls, the presymptomatic subjects performed significantly worse in executive oculomotor tasks such as the ability to perform correct anti-saccades. A gene mutation subgroup analysis showed that dysfunctions in C9orf72 carriers were much more pronounced than in SOD1 carriers. The anti-saccade error rate of ALS mutation carriers was associated with cognitive deficits: this correlation was increased in subjects with C9orf72 mutation, whereas SOD1 carriers showed no associations. In C9orf72 carriers, executive eye movement dysfunctions, especially the increased anti-saccade error rate, were associated with cognitive impairment and unrelated to time. These oculomotor impairments are in support of developmental deficits in these mutations, especially in prefrontal areas.

Identifiants

pubmed: 33709219
doi: 10.1007/s00415-021-10510-z
pii: 10.1007/s00415-021-10510-z
pmc: PMC8357645
doi:

Substances chimiques

C9orf72 Protein 0
C9orf72 protein, human 0
KIF5A protein, human 0
Multifunctional Enzymes 0
SETX protein, human EC 3.6.1.-
DNA Helicases EC 3.6.4.-
RNA Helicases EC 3.6.4.13
Kinesins EC 3.6.4.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3390-3399

Informations de copyright

© 2021. The Author(s).

Références

Acta Neuropathol. 2016 Sep;132(3):391-411
pubmed: 26910103
J Neurol Neurosurg Psychiatry. 2019 May;90(5):586-589
pubmed: 30257969
J Neurol. 2020 Oct 31;:
pubmed: 33130950
Lancet Neurol. 2013 Apr;12(4):368-80
pubmed: 23518330
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1138
pubmed: 32855286
Ann Neurol. 2018 Jul;84(1):130-139
pubmed: 30014505
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
Neuropsychologia. 2011 Jun;49(7):1794-806
pubmed: 21420990
BMC Neurol. 2012 Feb 29;12:5
pubmed: 22375860
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1195-1200
pubmed: 32855285
Ann Neurol. 1995 Jul;38(1):38-44
pubmed: 7611722
Brain Connect. 2013;3(3):265-72
pubmed: 23627641
J Eye Mov Res. 2019 Sep 16;12(6):
pubmed: 33828758
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):611-9
pubmed: 26283685
J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):102-8
pubmed: 21836033
Exp Brain Res. 1998 Aug;121(4):391-400
pubmed: 9746145
J Neurol. 2009 Sep;256(9):1438-46
pubmed: 19363627
Neurology. 2012 Oct 16;79(16):1732-9
pubmed: 23071166
Orphanet J Rare Dis. 2019 Nov 8;14(1):246
pubmed: 31703597
Arch Neurol. 2012 Apr;69(4):509-17
pubmed: 22491196
Lancet. 2017 Nov 4;390(10107):2084-2098
pubmed: 28552366
J Neurol. 2010 Jul;257(7):1134-40
pubmed: 20146069
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):374-6
pubmed: 27027323
Brain. 2008 May;131(Pt 5):1268-81
pubmed: 18362099
Cortex. 2018 Apr;101:163-171
pubmed: 29477906
PLoS One. 2014 Dec 11;9(12):e114543
pubmed: 25501028
Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):101-11
pubmed: 26312652
Front Neurol. 2018 Dec 05;9:1063
pubmed: 30568632
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):16-23
pubmed: 25292386
Lancet Neurol. 2007 Nov;6(11):994-1003
pubmed: 17945153
Exp Neurol. 2018 Jun;304:114-124
pubmed: 29522758
Muscle Nerve. 2019 Sep;60(3):232-235
pubmed: 31233613
Mov Disord. 2021 Apr;36(4):985-994
pubmed: 33438269
J Neurosci. 2018 Aug 29;38(35):7741-7752
pubmed: 30037833
PLoS One. 2015 Nov 11;10(11):e0142546
pubmed: 26559944
Exp Brain Res. 1992;89(2):415-24
pubmed: 1623983
J Neurol. 2014 Apr;261(4):791-803
pubmed: 24535136

Auteurs

Anna Behler (A)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Antje Knehr (A)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Julia Finsel (J)

Neuropsychology, Department of Neurology, University of Ulm, Ulm, Germany.

Martin S Kunz (MS)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Christina Lang (C)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Kathrin Müller (K)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Hans-Peter Müller (HP)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Elmar H Pinkhardt (EH)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Albert C Ludolph (AC)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.

Dorothée Lulé (D)

Neuropsychology, Department of Neurology, University of Ulm, Ulm, Germany.

Jan Kassubek (J)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany. jan.kassubek@uni-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH